_:b795383	<http://www.w3.org/1999/02/22-rdf-syntax-ns#rest>	_:b795384 .
_:b723087	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Restriction> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Class> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>etaracizumab</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000633070</n0:source-code></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>humanized monoclonal antibody MEDI-522</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000633069</n0:source-code></n0:ComplexTerm>" .
_:b723089	<http://www.w3.org/2002/07/owl#onProperty>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R125> .
_:b738638	<http://www.w3.org/1999/02/22-rdf-syntax-ns#first>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2144> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P329>	"38491"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P366>	"Vitaxin"^^<http://www.w3.org/2001/XMLSchema#string> .
_:b723088	<http://www.w3.org/2002/07/owl#someValuesFrom>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38953> .
_:b723090	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Restriction> .
_:b723090	<http://www.w3.org/2002/07/owl#onProperty>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R125> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#code>	"C1800"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://www.w3.org/2002/07/owl#equivalentClass>	_:b641204 .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P108>	"Etaracizumab"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P330>	"38491"^^<http://www.w3.org/2001/XMLSchema#string> .
_:b641204	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Class> .
_:b723088	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Restriction> .
_:b738638	<http://www.w3.org/1999/02/22-rdf-syntax-ns#rest>	_:b733659 .
_:b723087	<http://www.w3.org/2002/07/owl#someValuesFrom>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C13053> .
_:b723089	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Restriction> .
_:b723090	<http://www.w3.org/2002/07/owl#someValuesFrom>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C41585> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P210>	"892553-42-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P106>	"Immunologic Factor"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://linked.opendata.cz/ontology/mesh/hasConcept>	<http://linked.opendata.cz/resource/mesh/concept/M0522122> .
_:b795385	<http://www.w3.org/1999/02/22-rdf-syntax-ns#rest>	_:b795386 .
_:b795383	<http://www.w3.org/1999/02/22-rdf-syntax-ns#first>	_:b723087 .
_:b795384	<http://www.w3.org/1999/02/22-rdf-syntax-ns#rest>	_:b795385 .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>Abegrin</n0:term-name><n0:term-group>BR</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>Humanized Monoclonal Antibody LM609</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>Monoclonal Antibody Anti-alpha V Beta 3 Integrin MEDI-522</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P322>	"FDA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://www.w3.org/2000/01/rdf-schema#label>	"Etaracizumab"^^<http://www.w3.org/2001/XMLSchema#string> .
_:b723089	<http://www.w3.org/2002/07/owl#someValuesFrom>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26044> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P106>	"Amino Acid, Peptide, or Protein"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>Abegrin</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000641719</n0:source-code></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#A8>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923> .
_:b733659	<http://www.w3.org/1999/02/22-rdf-syntax-ns#rest>	_:b795383 .
_:b723087	<http://www.w3.org/2002/07/owl#onProperty>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R72> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>MEDI-522</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000633068</n0:source-code></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P319>	"41W9MFI160"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P325>	"<n0:ComplexDefinition xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:def-definition>A substance being studied in the treatment of some types of cancer and other conditions. Abegrin binds to a protein on the surface of blood vessels and may prevent the growth of new blood vessels that tumors need to grow. It may also prevent the spread of cancer. It is a type of antiangiogenesis agent, a type of metastasis inhibitor, and a type of monoclonal antibody.</n0:def-definition><n0:def-source>NCI-GLOSS</n0:def-source></n0:ComplexDefinition>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P303>	"Androgen-independent prostate cancer"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>MEDI-522</n0:term-name><n0:term-group>CN</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>Vitaxin</n0:term-name><n0:term-group>AQS</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P97>	"<n0:ComplexDefinition xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:def-definition>A humanized monoclonal IgG1 antibody directed against the vitronectin receptor alpha v beta 3 integrin. Etaracizumab blocks the binding of ligands, such as vitronectin, to alpha v beta 3 integrin, resulting in inhibition of angiogenesis and metastasis. Alpha v beta 3 integrin is a cell adhesion and signaling receptor that is expressed on the surface of tumor vessel endothelial cells, some tumor cells, and a number of other cell types.</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P175>	"719850"^^<http://www.w3.org/2001/XMLSchema#string> .
_:b795386	<http://www.w3.org/1999/02/22-rdf-syntax-ns#first>	_:b723090 .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>ETARACIZUMAB</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>FDA</n0:term-source><n0:source-code>41W9MFI160</n0:source-code></n0:ComplexTerm>" .
_:b733659	<http://www.w3.org/1999/02/22-rdf-syntax-ns#first>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C20401> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P207>	"C2350723"^^<http://www.w3.org/2001/XMLSchema#string> .
_:b723088	<http://www.w3.org/2002/07/owl#onProperty>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#R146> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>Monoclonal Antibody Anti-Avb3 Integrin Medi-522</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" .
_:b795385	<http://www.w3.org/1999/02/22-rdf-syntax-ns#first>	_:b723089 .
_:b795386	<http://www.w3.org/1999/02/22-rdf-syntax-ns#rest>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#nil> .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90>	"<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>Etaracizumab</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" .
<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1800>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#A7>	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38953> .
_:b795384	<http://www.w3.org/1999/02/22-rdf-syntax-ns#first>	_:b723088 .
_:b641204	<http://www.w3.org/2002/07/owl#intersectionOf>	_:b738638 .